Is COMT rs4680 AA linked to lower enzyme activity and sleep-maintenance insomnia?

The COMT rs4680 polymorphism plays a crucial role in regulating catecholamine degradation, directly impacting autonomic balance and sleep continuity.

Genetic and enzymatic mechanisms

• Reduced enzyme activity: The COMT rs4680 AA (Met/Met) genotype codes for a thermolabile variant of the catechol-O-methyltransferase (COMT) enzyme that degrades rapidly at body temperature. This results in a 3- to 4-fold reduction in catalytic activity in vitro and an approximate 40% decrease in functional activity in vivo.
• Prolonged adrenergic signaling: Because COMT is a primary pathway for inactivating dopamine, norepinephrine, and epinephrine, this genetic impairment directly slows metabolic clearance. Synaptic catecholamines persist longer in the extracellular space—particularly in regions with low transporter expression like the prefrontal cortex—leading to sustained downstream adrenergic receptor signaling.

Sleep architecture and hyperarousal

• Disrupted autonomic dipping: Consolidated sleep requires a shift toward parasympathetic dominance and a decline in sympathetic tone. Sustained central norepinephrine release from the locus coeruleus (LC)-norepinephrine system maintains elevated nocturnal catecholamine levels, preventing this critical autonomic "dipping" process.
• Cortical vigilance: Elevated norepinephrine activates $\alpha_1$- and $\beta$-adrenergic receptors, actively promoting cortical wakefulness and lowering the threshold for micro-arousals. This physiological hyperarousal shifts sleep architecture toward lighter stages, driving sleep fragmentation and sleep-maintenance insomnia (wake after sleep onset).
• Sympathetic feedback loop: Nocturnal arousal and sleep fragmentation trigger acute increases in sympathetic nervous system (SNS) activity. This creates a positive feedback loop, causing subsequent surges in catecholamines that further prevent the normal nighttime decline in sympathetic tone.

Bottom line

• The COMT rs4680 AA genotype represents a clear genetic driver of sleep-maintenance insomnia; its associated 40% reduction in functional COMT activity prolongs nocturnal adrenergic signaling, which prevents autonomic dipping and triggers a self-reinforcing loop of sympathetic hyperarousal.